Veeva Systems (NYSE:VEEV – Get Free Report) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.740-1.750 for the period, compared to the consensus earnings per share estimate of 1.620. The company issued revenue guidance of $726.0 million-$729.0 million, compared to the consensus revenue estimate of $725.8 million. Veeva Systems also updated its FY 2026 guidance to 7.320-7.320 EPS.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on VEEV shares. Truist Financial dropped their target price on Veeva Systems from $261.00 to $210.00 and set a “hold” rating for the company in a research note on Monday, January 13th. Wells Fargo & Company boosted their price target on Veeva Systems from $275.00 to $285.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Stifel Nicolaus boosted their price objective on shares of Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Mizuho began coverage on shares of Veeva Systems in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $275.00 target price on the stock. Finally, Bank of America lifted their target price on shares of Veeva Systems from $280.00 to $290.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Veeva Systems presently has an average rating of “Moderate Buy” and a consensus target price of $254.80.
Get Our Latest Analysis on Veeva Systems
Veeva Systems Price Performance
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Oversold Stocks With Major Reasons to Rebound
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Robinhood’s Rally: Is Global Expansion the Next Big Catalyst?
- How is Compound Interest Calculated?
- Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.